MedPath

Symptom Relief and Quality of Dying and Death (QODD) in Patients with Interstitial Lung Disease and Lung Cancer: A Multicenter Cross-sectional Study

Not Applicable
Conditions
Interstitial lung disease and lung cancer
Registration Number
JPRN-UMIN000045526
Lead Sponsor
Hamamatsu university school of medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
638
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who meet any of the following criteria will not be included in this study 1. Death due to adverse events or judged as treatment-related death. 2. The bereaved family (key person, underwriter) cannot be identified. 3. It is considered difficult for the bereaved family to answer questions about the care they received at the end of life due to restricted visitation. 4. The bereaved family is unable to fill out the survey form due to dementia, mental disability, or visual impairment at the time of discharge. 5. Based on the circumstances at the time of discharge and at present, the bereaved family member is mentally unstable, making it undesirable to conduct the study. 6. Implementation of the research is undesirable as a comprehensive judgment by doctors, nurses, and other multidisciplinary professionals due to strong distrust or misunderstanding of the medical care received or extremely poor relationships with medical personnel.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath